PharmaCyte Biotech (PMCB) Revenue (2010 - 2012)
PharmaCyte Biotech's (PMCB) quarterly Revenue came in at $6287.0 in Q4 2012, down 68.32% year-over-year from $19844.0 in Q4 2011, and down 5.12% quarter-over-quarter from $6626.0 in Q3 2012.
Analysis
PharmaCyte Biotech (PMCB) Revenue (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Revenue for 3 consecutive years, with $6287.0 the latest figure, recorded in Q4 2012.
- On a quarterly basis, Revenue fell 68.32% year-over-year to $6287.0 in Q4 2012; TTM through Jul 2013 was $6287.0, a 88.23% decrease from a year earlier, with the FY2013 full-year figure at $12160.0, down 81.73% from the prior year.
- Revenue was $6287.0 for Q4 2012 at PharmaCyte Biotech, down from $6626.0 in the prior quarter.
- Over five years, Revenue peaked at $51146.0 in Q2 2011 and troughed at $6287.0 in Q4 2012.
- A 3-year average of $20546.8 and a median of $19803.0 in 2011 frame the typical range for Revenue.
- Across the five-year window, Revenue climbed 25.05% in 2011 and sank 86.94% in 2012, its largest moves.
- Over 3 years, Revenue stood at $15869.0 in 2010, then climbed by 25.05% to $19844.0 in 2011, then plunged by 68.32% to $6287.0 in 2012.
- The last three Revenue figures came in at $6287.0 (Q4 2012), $6626.0 (Q3 2012), and $6681.0 (Q2 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 490,000.00 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 77.46 Mn |
| 10 | PharmaCyte Biotech | 3.98 Mn | 3.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2012 | 6,287.00 |
| Jul 31, 2012 | 6,626.00 |
| Apr 30, 2012 | 6,681.00 |
| Jan 31, 2012 | 20,271.00 |
| Oct 31, 2011 | 19,844.00 |
| Jul 31, 2011 | 19,762.00 |
| Apr 30, 2011 | 51,146.00 |
| Jan 31, 2011 | 32,022.00 |
| Oct 31, 2010 | 15,869.00 |
| Jul 31, 2010 | 26,960.00 |